Why uncovering workings of the bacterial “immune system” is crucial?

Washington, April 1 (ANI): Understanding the functioning of the bacterial “immune system” can help to keep industrial microbes at peak performance, a microbiologist has suggested.

Addressing the Society for General Microbiology”s spring meeting, Professor John van der Oost said viruses can wreak havoc on bacteria as well as humans.

Just like humans, bacteria have their own defence system in place, said Prof van der Oost.

Professor van der Oost and his colleagues at Wageningen University in the Netherlands have spent the last three years working out the molecular details of the immune system called CRISPR that is present in bacteria.

The recently discovered CRISPR defence system differs from the immune system in higher organisms in that acquired immunity can be passed down future generations.

This means bacterial offspring are protected from viral attack even before they are exposed to the invading virus.

Specific bacterial proteins recognise infectious viruses, called bacteriophages, by detecting foreign DNA. These proteins take the viral DNA and insert it into the bacterial genome at very specific locations.

Prof van der Oost explained: “Storing the information in this way gives the bacteria a lasting ”memory” of the harmful virus that subsequently confers immunity- much like our own immune systems.”

Upon future attack by the same virus, the DNA sequence of the invader is quickly recognised and destroyed by the bacteria.

Understanding the exact mechanisms of the CRISPR defence system could have big economic rewards for industry.

Prof van der Oost added: “We can exploit this system and expose bacteria to artificial or modified bacteriophages whose DNA could be stored. This would be exactly like giving them a flu jab and protect them against a real attack in the future. For industrially-important bacteria this could be a great cost-saving method to reduce viral infections that may compromise yields of bacterial products. It”s a classic example of vaccinating the workforce to increase its productivity.” (ANI)

Novel stem cell therapy to tackle HIV

Washington, Apr 1 (ANI): A novel stem cell therapy could in the future be used to treat HIV, say researchers.

Researchers are studying a new approach that arms the immune system with an intrinsic defence against HIV.

While speaking at the Society for General Microbiology”s spring meeting in Edinburgh, Professor Ben Berkhout explained how this new approach could dramatically improve the quality of life and life expectancy for HIV sufferers in whom antiviral drugs are no longer effective.

In the absence of an effective vaccine, daily administration of anti-retroviral drugs is the most effective treatment for HIV. However, low patient compliance rates combined with the virus”s ability to easily mutate has led to the emergence of drug-resistant strains that are difficult to treat.

Professor Berkhout from the University of Amsterdam is investigating a novel gene therapy that has long-lasting effects even after a single treatment. It involves delivering antiviral DNA to the patients” own immune cells that arms them against viral infection. “This therapy would offer an alternative for HIV-infected patients that can no longer be treated with regular antivirals,” he suggested.

The therapy involves extracting and purifying blood stem cells from the patient”s bone marrow. Antiviral DNA is transferred to the cells in the laboratory, after which the cells are re-injected into the body. The DNA encodes tiny molecules called small RNAs that are the mirror image of key viral genes used by HIV to cause disease. The small RNAs float around inside the immune cell until they encounter viral genes which they can stick to like Velcro(tm). This mechanism, called ”RNA interference” can block the production of key viral components from these genes.

Transferring the antiviral DNA to stem cells would help to restore a large part of the patient”s immune system. “Stem cells are the continually dividing ”master copy” cells from which all other immune cells are derived. By engineering the stem cells, the antiviral DNA is inherited by all the immune cells that are born from it,” explained Professor Berkhout. (ANI)

Essential oils may combat drug-resistant superbugs

Washington, March 31(ANI): A new study has found that essential oils can be used as an effective and cheap alternative to antibiotics against drug-resistant hospital superbugs.

Professor Yiannis Samaras and Dr Effimia Eriotou, from the Technological Educational Institute of Ionian Islands, in Greece, led the research.

The experts tested the antimicrobial activity of eight plant essential oils.

It was observed that thyme essential oil completely eliminated bacteria within 60 minutes.

Apart from thyme, cinnamon oil was also found to be efficient antibacterial agents against a range of Staphylococcus species.

These bacteria often lead to infection in immunocompromised individuals.

Samaras said: “Not only are essential oils a cheap and effective treatment option for antibiotic-resistant strains, but decreased use of antibiotics will help minimise the risk of new strains of antibiotic resistant micro-organisms emerging.”

Essential oils have been used for hundreds of years for therapeutic purpose, even though it is little known. Australian aborigines used Tea tree oil to treat colds, sore throats, skin infections and insect bites.

The Greek team believes essential oils could have diverse medical and industrial applications.

The team said: “The oils – or their active ingredients – could be easily incorporated into antimicrobial creams or gels for external application. In the food industry the impregnation of food packaging with essential oils has already been successfully trialled. They could also be included in food stuffs to replace synthetic chemicals that act as preservatives.”

The research was presented at the Society for General Microbiology”s spring meeting in Edinburgh this week. (ANI)

Sex infection gonorrhoea becoming “superbug”

Washington, March 30 (ANI): Gonorrhoea-causing bacteria develops resistance to antibiotics quite quickly and if new treatment is not considered soon the sexually transmitted infection may become extremely difficult to treat, an expert has warned.

Addressing the Society for General Microbiology”s spring meeting in Edinburgh, professor Catherine Ison said it was quite possible that strains of Neisseria gonorrhoeae resistant to all current treatment options could emerge in the near future.

Prof Ison, from the Health Protection Agency (HPA) in London, explained how some strains of the gonococcal bacteria that cause the disease are now demonstrating decreased sensitivity to the current antibiotics used to treat them – ceftriaxone and cefixime.

Gonorrhoea is a common bacterial sexually-transmitted infection and if left untreated can lead to pelvic inflammatory disease, ectopic pregnancy and infertility in women.

Current treatment consists of a single dose of antibiotic given in the clinic when prescribed, by mouth for cefixime and by injection for ceftriaxone.

Prof Ison said: “Choosing an effective antibiotic can be a challenge because the organism that causes gonorrhoea is very versatile and develops resistance to antibiotics very quickly.

“Penicillin was used for many years until it was no longer effective and a number of other agents have been used since. The current drugs of choice, ceftriaxone and cefixime, are still very effective but there are signs that resistance particularly to cefixime is emerging and soon these drugs may not be a good choice.”

Bacteria isolated from patients diagnosed with gonorrhoea are tested for their susceptibility to various antibiotics to monitor patterns of resistance at a local and national level.

Ongoing monitoring of antimicrobial resistance is critical to ensure that first-line treatments for gonorrhoea remain effective.

Professor Ison said: “There are few new drugs available and so it is probable that the current use of a single dose may soon need to be revised and treatment over several days or with more than one antibiotic will need to be considered.”

“If this problem isn”t addressed then there is a real possibility that gonorrhoea will become a very difficult infection to treat,” she added. (ANI)

Producing better wine by taking the stress off yeast

Washington, Sept 9 (ANI): Times can be stressful for yeast when grape juice is being turned into wine. Now, a researcher from the University of Valencia, Spain has identified the genes in yeast that enable it to respond to stress.

What’s more, Dr Agustin Aranda is investigating ways to improve yeast performance by modifying its stress response mechanism.

Speaking at the Society for General Microbiology meeting at Heriot-Watt University, Edinburgh, Aranda described the stresses that wine yeasts undergo in the fermentation process. Industrial wine making involves adding dried yeast starter cultures to the juice; both the drying and reactivating processes cause stress damage to the yeast cells. As the juice is fermented into wine the rising ethanol (alcohol) levels also damage the yeast cells and oxidation causes further damage.

By manipulating the genes that control the stress response of the yeast, the researchers found that they could improve its performance in industrial fermentation processes. hey found that a family of enzymes called sirtuins had an important role in controlling wine yeast lifespan.

“Our research aimed to improve winemaking techniques but our findings on oxidative stress and ageing in yeast could be potentially useful in understanding the positive roles of antioxidants present in grapes and grape juice,” said Aranda. (ANI)

Researchers make bacteria to produce useful proteins

Washington, Sep 7 (ANI): Researchers at the University of British Columbia have turned the bacterium Caulobacter crescentus into a protein production factory by adapting a single protein on its surface, thus making useful proteins that can act as vaccines and drugs.

C. crescentus is a harmless bacterium that has a single protein layer on its surface.

Led by Dr. John Smit, the researchers adapted the system that secretes this protein, which self-assembles into a structure called the “S-layer”, to secrete instead many proteins that are useful for vaccines and other therapeutic purposes.

In other words, by keeping the S-layer protein intact and genetically inserting new things inside it, they produce a very dense display of useful proteins on the cell surface.

The researchers are now hoping to use the entire bacterium in a therapeutic application.

Bacteria are commonly used in biotechnology to produce useful protein products.

If the bacteria secrete the protein rather than keep it contained within the cell, purification costs are greatly lowered.

The researchers have developed a commercially available kit based on this technology, which could be especially useful in developing countries as it might be used to manufacture HIV-blocking agents very cheaply and with little specialist expertise.

“This S-layer system is very efficient at producing and secreting proteins – we can make the bacterium into a protein pump, secreting over half of all the protein it makes as engineered S-layer protein,” said Smit.

He added: “Applications of S-layer display that we are currently developing include anti-cancer vaccines, an HIV infection blocker and agents to treat Crohn’s and colitis, and diarrhoea in malnourished populations”.

Smit presented the findings at the Society for General Microbiology’s meeting at Heriot-Watt University, Edinburgh. (ANI)

Secret behind how manuka honey fights infection revealed

Washington, Sep 7 (ANI): Scientists at the University of Wales Institute, Cardiff, have uncovered how manuka honey can help fight infection-by destroying key bacterial proteins.

Led by Dr. Rowena Jenkins, the research team investigated the mechanisms of manuka honey action.

They found that its anti-bacterial properties were not due solely to the sugars present in the honey.

They grew Meticillin resistant Staphylococcus aureus (MRSA) in the laboratory, and treated it with and without manuka honey for four hours.

The experiment was repeated with sugar syrup to determine whether the effects seen were due to sugar content in honey alone.

The bacterial cells were then broken and the proteins isolated and separated on a system that displayed each protein as an individual spot.

The researchers saw many fewer proteins from the manuka honey-treated MRSA cells, and one particular protein called FabI seemed to be completely missing.

FabI is a protein that is needed for fatty acid biosynthesis.

This essential process supplies the bacteria with precursors for important cellular components such as lipopolysaccarides and its cell wall.

The scientists said that the absence of those proteins in honey-treated cells could help explain the mode of action of manuka honey in killing MRSA.

“Manuka and other honeys have been known to have wound healing and anti-bacterial properties for some time. But the way in which they act is still not known. If we can discover exactly how manuka honey inhibits MRSA it could be used more frequently as a first-line treatment for infections with bacteria that are resistant to many currently available antibiotics,” said Jenkins.

The work was presented at the Society for General Microbiology’s meeting at Heriot-Watt University, Edinburgh. (ANI)

Scientists uncover how probiotics can prevent disease

Washington, Apr 2 (ANI): Scientists have now discovered how probiotics successfully work in fighting against a number of animal diseases, paving way for their use in preventing and even treating human diseases.

Scientists from University College Cork, Ireland, used three animal models of disease that have human counterparts – bovine mastitis, porcine salmonellosis (a gastrointestinal disease) and listeriosis in mice (an often fatal form of food poisoning) – to demonstrate the protective effects of probiotics.

“Rather than use commercially available probiotics, we made our own probiotic preparations containing safe bacteria such as Lactobacillus species newly isolated from human volunteers,” said Dr. Colin Hill, the lead researcher of the study.

He added: “In all three animal diseases we observed a positive effect in that the animals were significantly protected against infection”.

Also, the researchers used probiotics to control disease in animals that were already infected.

And the researchers saw that administering these safe bacteria to an infected animal was equally effective as the best available antibiotic therapies in eliminating the infectious agent and resolving the symptoms.

Also, it was found that the protection, in each instance, was linked to a particular bacterial species, and the mechanism of action varied from direct antagonism (where the probiotic directly kills the pathogenic bacteria) to effects mediated by the host immune system.

“It is likely that using probiotics rather than antibiotics will appeal to at-risk individuals since they are safe, non-invasive, do not create resistant bacteria and can even be administered in the form of tasty foods or beverages,” Hill said.

“We have shown that we can protect and even treat animals against pathogenic bacteria by introducing harmless bacteria at the site of the infection.

“In order to use similar strategies in preventing or treating human disease we must understand the molecular basis of their efficacy. This understanding will provide the basis for intelligent screening and selection of the most appropriate protective bacterial cultures to go forward into human trials,” Hill added.

The study was presented at the Society for General Microbiology meeting in Harrogate. (ANI)

Light-activated antibacterial coating may help fight hospital-acquired infections

Washington, Mar 31 (ANI): Scientists at the UCL Eastman Dental Institute have developed a new tool to combat hospital-acquired infections- antibacterial coating that is activated by light.

The research team, led by Zoie Aiken, have tested the new coating with antibacterial properties, and found that it could kill 99.9 percent of Escherichia coli bacteria when a white hospital light was shone on its surface to activate it.

Made of titanium dioxide with added nitrogen, the veneer-like surface, when activated by white light-similar to those used in hospital wards and operating theatres-produced a decrease in the number of bacteria surviving on the test surface.

The hospital environment is usually full of microbes responsible for healthcare-associated infections (HCAI).

Thus, there’s a need for new ways to prevent the spread of these pathogens to patients.

And it is possible to apply antibacterial coatings to frequently touched hospital surfaces to kill any bacteria present and help reduce the number of HCAI.

Titanium dioxide based coatings can kill bacteria after activation with UV light.

And the addition of nitrogen to these coatings enables photons available in visible light to be utilised to activate the surface and kill bacteria.

Aiken said: “The activity of the coating will be assessed against a range of different bacteria such as MRSA and other organisms which are known to cause infections in hospitals. At present we only know that the coating is active against Escherichia coli. However, E. coli is more difficult to kill than bacteria from the Staphylococcus group which includes MRSA, so the results to date are encouraging.

“The coating has currently been applied onto glass using a method called APCVD (atmospheric pressure chemical vapour deposition.

“We are also experimenting with different materials such as plastic. As an example, the coating could be applied to a plastic sheet that could be used to cover a computer keyboard on a hospital ward. The lights in the ward will keep the coating activated, which will in turn continue to kill any bacteria that may be transferred onto the keyboard from the hands of healthcare workers.”

The study was presented at the Society for General Microbiology meeting in Harrogate. (ANI)

Diets rich in meat and fats and low in carbohydrates up colon cancer risk

Washington, March 31 (ANI): Diets rich in meat and fats and low in complex carbohydrates may increase the risk of colon cancer, say U.S. researchers.

Speaking at the Society for General Microbiology meeting at Harrogate, University of Pittsburgh’s Professor Stephen O’Keefe described an expanding body of evidence to show that the composition of the diet directly influences the diversity of the microbes in the gut, providing the link between diet, colonic disease and colon cancer.

He said that people who ate a healthy diet, containing high levels of complex carbohydrate, had significant populations of micro-organisms in their gut called Firmicutes.

O’Keefe pointed out that such bacteria use the undigested residues of starch and proteins in the colon to manufacture short-chain fatty acids and vitamins like folate and biotin, which maintain colonic health.

A fatty acid called butyrate not only provides most of the energy to maintain a healthy gut wall, but also regulates cell growth and differentiation, said the researcher.

According to him, experimental and human studies both support butyrate’s role in reducing colon cancer risk.

However, added the researcher, diets rich in meat produce sulphur, which decreases the activity of “good” bacteria that use methane and increases the production of hydrogen sulphide and other possible carcinogens by sulphur-reducing bacteria.

“Colon cancer is the second leading cause of cancer-related deaths in adults in Westernised communities. Our results suggest that a diet that maintains the health of the colon wall is also one that maintains general body health and reduces heart disease,” said Professor O’Keefe.

“A diet rich in fibre and resistant starch encourages the growth of good bacteria and increases production of short chain fatty acids which lessen the risk of cancer, while a high meat and fat diet reduces the numbers of these good bacteria.

“Our investigations to date have focused on a small number of bacterial species and have therefore revealed but the tip of the iceberg, our colons harbour over 800 bacterial species and 7,000 different strains. The characterization of their properties and metabolism can be expected to provide the key to colonic health and disease,” the researcher added. (ANI)

Brushing teeth ‘can help reduce pregnancy complications’

Washington, Mar 31 (ANI): Expecting mothers could reduce the risk of complications in their pregnancies and new-born babies by paying closer attention to oral hygiene, scientist have suggested.

Bacteria from a mother’s mouth can be transmitted through the blood and amniotic fluid in the womb to her unborn child.

This could contribute to the risk of a premature delivery, a low birth-weight baby, premature onset of contractions, or infection of the newborn child.

Ms Cecilia Gonzales-Marin and colleagues from Queen Mary University of London, tested the gastric aspirates (stomach contents containing swallowed amniotic fluid) of 57 newborn babies and found 46 different species of bacteria in the samples.

The most prevalent bacteria in the samples may have come from the vagina; however, two of the species were recognised as coming from the mouth and are not normally found elsewhere in the body.

These particular bacteria, Granulicatella elegans and Streptococcus sinensis, are known to be able to enter the bloodstream and have previously been associated with infections remote from the mouth such as infective endocarditis.

“Our studies show that sampling the stomach contents of newborn babies by using gastric aspirates can provide a reliable method of microbial identification. Hospitals routinely take these samples as part of the care of the babies born from a complicated pregnancy and/or at risk of serious infection. They provide a more accessible alternative to amniotic fluid,” said Ms Gonzales-Marin,

“Our research group is using DNA techniques to confirm if bacteria from the newborn matches the bacteria in the respective mother’s mouth,” Gonzales-Marin added.

The study has been presented at the Society for General Microbiology meeting in Harrogate. (ANI)

Handwashing may be best way to fight MRSA

Washington, Mar 31 (ANI): Regular handwashing by hospital staff and visitors could be more effective at controlling the spread of the hospital superbug MRSA than isolating infected patients, according to a new study.

Dr Peter Wilson from University College Hospital, London, conducted a year-long study in two hospital intensive care units.

In the middle six months of the year patients with MRSA were not moved to single rooms or nursed in separate MRSA bays.

The rates of cross infection with MRSA were compared to the periods when patients were moved.

Patients were tested for MRSA weekly and hand hygiene by staff and visitors audited and encouraged.

Wilson said that there was no evidence of increased transmission of infection when patients were not moved.

Moving seriously-ill patients when they are identified as having MRSA can be hazardous and it involves ward staff in extra hygiene measures.

“If a patient carrying MRSA is critically ill, moving them to a single room is less of a priority than clinical care,” said Dr Wilson.

“If the criteria are strictly applied, compliance with hand hygiene practices on intensive care units is less than on a general ward because of the very high number of contacts per hour. Another study is needed in a general ward where a high level of compliance with hand hygiene is easier to achieve,” he added.

The research has been presented at the Society for General Microbiology meeting in Harrogate. (ANI)

World War disease’s bug may adversely affect poultry, diabetics

Washington, Mar 30 (ANI): The bacterium responsible for gas gangrene, the notorious infectious disease of two world wars, can also cause necrotic enteritis in intensively raised chickens.

The frequently fatal disease has significant financial implications for the poultry industry.

Professor Richard Titball of the University of Exeter highlighted the finding while addressing the Society of General Microbiology Meeting at the International Centre, Harrogate.

Intensive study of Clostridium perfringens during World War 2 showed that the bacterium produces a potent toxin.

Recently, researchers used modern molecular genetic approaches and the work provided an insight into the role of this toxin in disease.

The toxin produced by C. perfringens works in three ways- by promoting a reduction in blood supply to infected tissues; by increasing inflammation; and by having a toxic effect on the heart.

“Gas gangrene is not just a historical curiosity”, said Professor Titball,

He added: “In the past it has been a major cause of death and disability in servicemen injured on the battlefield, although it is rarely a problem now because of the prompt treatment that casualties receive. However it does occasionally occur in the civilian population with diabetes patients, with the elderly being most at risk.

“In the future, the incidence of gangrene infection may rise in line with the increase in this age group in the general population. It is essential to understand how the toxin works to prevent future disease not only in diabetes sufferers but also in intensively reared animals”.(ANI)

Drug resistant HIV ‘spreads between people without anti-retroviral treatment’

Washington, Mar 30 (ANI): A professor from University College, London has said that drug-resistant forms of HIV can be spread between individuals who have not received anti-retroviral treatment.

Professor Deenan Pillay from University College, London and the Health Protection Agency highlighted the finding while speaking at the Society for General Microbiology meeting at Harrogate.

Anti-retroviral therapy is a major advance in the treatment of HIV and there are currently over 25 drugs available.

Scientists already know that the virus can mutate, reducing its susceptibility to treatment, and that these resistant viruses can be transmitted between individuals.

Pillay found that drug resistant viruses could also circulate between individuals who have not received antiretroviral drugs treatments.

“Our findings show that assuming that drug resistant HIV was only passed on from individuals receiving drug treatment may mean the number and size of the reservoirs of drug resistant virus in the United Kingdom has been underestimated,” said Pillay.

He added: “Our results indicate that although the incidence of drug resistance has been declining, this might not continue – which could have implications for planning and management of treatment programmes”. (ANI)

Tea tree oil, silver combo can make for effective antiseptics

Washington, Mar 30 (ANI): A combination of tea tree oil and silver can make for an effective antiseptic for skin wounds, says a new study.

The research team led by Wan Li Low from the University of Wolverhampton showed that mixing tea tree oil and silver (in the form of silver nitrate) or putting them in liposomes, (small spheres made from natural lipids), greatly increases their antimicrobial activity and minimise side effects.

During the study, the researchers found that low concentrations of two agents significantly increased their antimicrobial activity.

They focused on bacteria such as Staphylococcus aureus and the yeast Candida albicans, which cause skin infections.

To reach the conclusion, researchers used microscopic spherical bodies called liposomes, made of phospholipids, the naturally occurring lipids or fats in the cell wall membranes, to deliver the silver and tea tree oil mix to infected wounds.

This lead to a controlled release and therefore, a potential to use lower, less toxic, concentrations of the antimicrobial agents to treat infected wounds.

It can also be used for treating antibiotic resistant strains such as MRSA.

Current treatments using traditional silver-based creams and dressings use relatively high metal concentrations.

The creams containing lower amounts of the agents could provide safer and readily available over-the-counter antiseptic compounds for effective treatment without damaging the surrounding skin.

The findings are to be presented at the Society for General Microbiology meeting in Harrogate. (ANI)

Discovery of slow-growing TB bacteria may pave way for new drugs

Washington, March 30 (ANI): Scientists have found a large number of slow-growing Mycobacterium tuberculosis bacteria in the lungs of TB patients, which can pave the way for new medicines for treating the disease.

Dr Simon Waddell and his colleagues, from St George’s University of London and the University of Leicester, point out that scientists have always thought that M. tuberculosis bacteria in the lungs of TB patients are rapidly multiplying.

However, the researchers add, when they used gene chips to look at how TB bacteria behave in different environments, they observed that the bacteria in the sputum-phlegm coughed from the lungs-of patients with the disease resembled bacteria that are growing very slowly or hardly at all.

The researcher said that the finding has caused concern because slowly growing bacteria are non-responsive to treatment with isoniazid, one of the main antibiotics used to treat TB.

According to them, this may be the reason why it takes six months to treat pulmonary TB successfully, while most bacterial infections are treated in days.

The team further point out that the prolonged treatment often causes patients to stop taking their medicines early or to take them intermittently, which can cause relapses and the emergence of antibiotic resistance.

“Our observations imply that either a large number of the infecting bacteria in the lungs are not multiplying rapidly as previously suggested; or the bacteria are adapting by not growing when they are coughed from the lungs into the air,” said Dr Waddell.

“We need to find out how bacteria respond during infection and after drug treatment to understand how bacteria become tolerant to antibiotics. This will provide alternative opportunities for the development of better drugs that the world desperately needs to combat the growing health threat of TB,” he added.

Waddell presented his team’s findings at the Society for General Microbiology meeting at Harrogate on March 30. (ANI)